We narrowed to 715 results for: mak

...target cells (Beatty et al., 2012). These features make AdV an attractive candidate for in vivo delivery...

...and more photostable than fluorescent proteins, making them ideal for single-molecule fluorescence techniques...

...that they don’t always require needles. If needles make you cringe or your experiment will allow you to ...

...of rAAV production.  Of course, you will want to make sure that your final stocks only contain rAAV. To...

...summaries of recent plasmid deposits and we hope they'll make it easier for you to find and use the plasmids you...

...interested in viewing which has drawn a large crowd, making it difficult to see the actual poster or interact...

...translated at the ribosome into polypeptide chains that make up the primary structure of proteins. Most proteins...

...if you’d like to use homology directed repair to make precise edits or knock-ins. Editing efficiency decreases...

...degron will behave with a new protein, but you can make an informed choice!   References and Resources ...

...ability to differentiate into multiple cell types makes them useful models for developmental processes and...

... protein characteristics. For example, Masato Kanemaki's lab has developed a CRISPR/Cas-based system for...

...will ‘look’ similar on your flow plot. This will make it difficult to properly gate your desired cell ...

...is required for NgAgo optimization before we can make any major conclusions: That said, many people are...

...don’t require a PAM sequence at the target locus, making them more flexible than Cas9/Cpf1. Some Cas13 enzymes...

...added log-normal noise to each of the terms which make up our distribution, resulting in the following ...

...number of administrative and practical decisions to make. How often will you hold it? How many people do ...

...decide which ones to use? Here are some tips for making those decisions: Always always always look at ...

... Using this technique, researchers have begun to make important discoveries in various biological fields...

...started, and 10 more years to obtain FDA approval and make history in the form of Luxturna™. A better vector...

...domain proteins, they can be expressed in bacteria, making nanobodies a recombinant and renewable anti-IgG...